Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer

Clinical trial NCT03382561 · COMPLETED

Trial details

NCT number: NCT03382561
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Stage Lung Small Cell Carcinoma Recurrent Lung Small Cell Carcinoma

Start date: 2018-05-21
Primary completion: 2022-02-16
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.